Login

CHIMERIX INC 3 SEC Filings

Filed On Filing
21 Mar 2024 Form 3: Kozin Marc D, Director

No securities owned

02 Jan 2024 Form 3: Decker Lisa Lynn, Director

Holds 0 shares of No securities are beneficially owned

04 Dec 2023 Form 3: LaSpaluto Michelle, Chief Financial Officer

Holds 87,939 shares of Common Stock

16 Nov 2023 Form 3: Riga Thomas J, COO and CCO

Holds 0 shares of No securities are beneficially owned

30 Mar 2022 Form 3: Alrutz Michael Albert, Principal Executive Officer

Holds 119,543 shares of Common Stock

26 Apr 2021 Form 3: Vakiener Victoria, Director

Holds 0 shares of No securities are beneficially owned

23 Jun 2020 Form 3: Melemed Allen S., Chief Medical Officer

Holds 0 shares of No securities are beneficially owned

25 Feb 2020 Form 3: Multani Pratik S, Director

Holds 0 shares of No securities are beneficially owned

06 Aug 2019 Form 3: Cantex PHARMACEUTICALS, Inc., 10% owner

Holds 10,000,000 shares of Common Stock, Par Value $0.001 per share

24 Jun 2019 Form 3: Jakeman David, Principal Accounting Officer

Holds 20,006 shares of Common Stock

09 Apr 2019 Form 3: Sherman Michael A., Director

Holds 0 shares of No securities are beneficially owned

09 Apr 2019 Form 3: Andriole Michael T., Chief Business Officer

Holds 0 shares of No securities are beneficially owned

07 Feb 2019 Form 3: Alrutz Michael Albert, Principal Executive Officer

Holds 56,645 shares of Common Stock

06 Apr 2018 Form 3: Meyer Robert J., Director

No securities owned

06 Apr 2018 Form 3: Middleton Fred A, Director

Holds 2,776,093 shares of Common Stock

06 Apr 2018 Form 3: Greissing Ed, Director

No securities owned

18 Dec 2014 Form 3: Renaud Ronald C Jr, Director

No securities owned

04 Sep 2014 Form 3: Nichols Garrett, Chief Medical Officer

No securities owned

24 Jun 2014 Form 3: Leonard John M., Director

No securities owned

23 Jun 2014 Form 3: Daly James M, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support